ArticleAtherosclerosis2020

Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors.

Loukianos S Rallidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.